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Background
Nitric oxide binds with the heme moiety of sGC and
activates sGC several hundred folds the cGMP-forming
activity of the enzyme. Although nitric oxide is the
major physiological regulator of sGC function, the
extent of this activation is influenced by a number of
cellular factors, e.g. ATP, substrate GTP, reaction pro-
ducts, intracellular calcium, etc. Several proteins, such
as HSP70, HSP90 and CCTh,w h e r es h o w nt oi n t e r a c t
with sGC and modulate its function.
Results
In this report we provide evidence that demonstrate
inhibition of sGC by a LGN-dependent mechanism.
LGN, a Leu-Gly-Asn repeat enriched protein, is a
known guanosine diphosphate (GDP) dissociation inhi-
bitor, which regulates the Gaif a m i l yo fGp r o t e i n s .
Using the yeast two-hybrid screening, we identified
LGN as a protein that interacts with both a1a n db1
subunits of sGC. This interaction was confirmed by co-
immunoprecipitation of sGC and LGN proteins from
the lysate of BE2 human neuroblastoma cell line. Tran-
sient overexpression of LGN in sGC expressing
MDA468 breast cancer cell line markedly decreased the
activity of sGC in cell lysates in a gene-dose dependent
fashion. On the contrary, inhibition of LGN expression
by targeted siRNA increased sGC activity in the cellular
lysates. In vitro pull-down experiments performed with
t r u n c a t e dv e r s i o n so fL G Na n ds G Cm a p p e dt h e
domains required for interaction between LGN and
sGC. However, when the effect of purified LGN protein
on the activity of purified sGC was tested in vitro, we
found no evidence of inhibition, suggesting that LGN
does not directly affect sGC function. When the same
experiment was performed in the lysate of COS7 cell,
we observed a marked inhibition of sGC.
Conclusion
These data suggest that LGN may function as an adap-
tor protein for additional cellular factors inhibiting sGC.
Since LGN is a known regulator of G-protein, which
associates with Ga subunit, it may function as an adap-
tor protein for a complex consisting of sGC, LGN and
Ga, thus connecting the NO-dependent and G-protein
signaling pathways.
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